Article Details
Retrieved on: 2021-04-23 21:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Aducanumab, a monoclonal antibody that selectively binds to aggregated forms of amyloid beta, has raised considerable controversy in the wake of ...
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here